Results 1 to 10 of about 94,325 (274)
Life, 2022 Thyroid eye disease (TED), an autoimmune inflammatory disorder of the orbit, presents with a potential array of clinical sequelae. The pathophysiology behind TED has been partially characterized in the literature.
Ramy Rashad +4 more
doaj +3 more sources
Graves’ ophthalmopathy – thyroid eye disease
Journal of Education, Health and Sport, 2019 Graves’ disease (GD) is an autoimmune disorder that affects thyroid. It is caused by antibody, named thyroid-stimulating immunoglobulin (TIS) that acts like thyroid stimulating hormone (TSH), resulting in thyroid hormone overproduction – condition called
Dagna Siedlecka +3 more
doaj +5 more sources
Successful outcome of Rituximab treatment based on lymphocyte immunophenotyping in active Thyroid Eye Disease: a case report [PDF]
Thyroid ResearchBackground Rituximab, an anti-CD20 monoclonal antibody that depletes B-cells, is a potential second-line treatment for moderate-to-severe active Thyroid Eye Disease that is resistant to steroids.
Mirco Armenti +6 more
doaj +2 more sources
Editorial: Thyroid eye disease [PDF]
Frontiers in OphthalmologyAlon Kahana +6 more
doaj +2 more sources
QJM, 2015 A 72-year-old man presented to the emergency with dizziness and progressive double vision for one month. He was diagnosed as Graves’ disease at another medical center at his age of 60, and he had received antithyroid medication with restoration of euthyroidism. There had been no ocular abnormality until 6 years ago, when proptosis occurred. In addition,
H-J, Hsu, C-K, Hsu, T-S, Chen, C-H, Hsu
+5 more sources
Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
Clinical Case Reports, 2022 A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine.
Solange Grunenwald +4 more
doaj +1 more source
Sphingolipids in thyroid eye disease
Frontiers in Endocrinology, 2023 Graves’ disease (GD) is caused by an autoimmune formation of autoantibodies and autoreactive T-cells against the thyroid stimulating hormone receptor (TSHR).
Anne Gulbins +3 more
doaj +1 more source
BMC Ophthalmology, 2023 Background Thyroid eye disease is an extrathyroidal manifestation of Graves’ disease and is associated with dry eye disease. This is the first systematic review and meta-analysis to evaluate the role of magnetic resonance imaging lacrimal gland ...
Nicole Tsz Yan Wong +8 more
doaj +1 more source
Horizontal eye position in thyroid eye disease: a retrospective comparison with normal individuals and changes after orbital decompression surgery. [PDF]
PLoS ONE, 2014 To compare horizontal eye positions between proptotic thyroid eye disease patients and normal individuals, and to examine positional changes after orbital decompression surgery in thyroid eye disease patients.The present case-controlled and retrospective
Yasuhiro Takahashi, Hirohiko Kakizaki
doaj +1 more source
Canadian Medical Association Journal, 2013 About 90% of patients with thyroid eye disease have Graves hyperthyroidism, but hypothyroidism and euthyroidism can also accompany this condition.[1][1] Eye disease usually develops in patients with hyperthyroidism within the first 1–2 years, but the disease can occur decades later.
Michel J, Belliveau, David R, Jordan
openaire +2 more sources